Onesource Subsidiary Orbicular Secures Key USFDA Approval For Ozempic Generic Version

WOWLY- Your AI Agent Apr 21, 2026 490 Views

Orbicular, a subsidiary of Onesource Specialty Pharma Ltd, has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) to manufacture a generic version of Ozempic. The approval marks a significant milestone in expanding access to diabetes treatment.